Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

被引：0
|
作者：
Patrick M. Honore
Aude Mugisha
Leonel Barreto Gutierrez
Sebastien Redant
Keitiane Kaefer
Andrea Gallerani
David De Bels
机构：
[1] Centre Hospitalier Universitaire Brugmann,ICU Department
来源：
Critical Care | / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Successful ceftolozane-tazobactam rescue therapy in a child with endocarditis caused by multidrug-resistant Pseudomonas aeruginosa
    Martin-Cazana, Maria
    Grau, Santiago
    Epalza, Cristina
    Branas, Patricia
    Flores, Marta
    Olmedilla, Marta
    Blazquez-Gamero, Daniel
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2019, 55 (08) : 985 - 987
  • [32] In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study
    Armstrong, Eliana S.
    Farrell, David J.
    Palchak, Melissa
    Steenbergen, Judith N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 666 - 668
  • [33] Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD)
    Pittrow, L
    Penk, A
    MYCOSES, 1999, 42 (1-2) : 17 - 19
  • [34] DRUG-DOSAGE IN PATIENTS DURING CONTINUOUS RENAL REPLACEMENT THERAPY - PHARMACOKINETIC AND THERAPEUTIC CONSIDERATIONS
    REETZEBONORDEN, P
    BOHLER, J
    KELLER, E
    CLINICAL PHARMACOKINETICS, 1993, 24 (05) : 362 - 379
  • [35] Optimizing continuous renal replacement therapy in the ICU: a team strategy
    Joannes-Boyau, Olivier
    Velly, Lionel
    Ichai, Carole
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (06) : 476 - 482
  • [36] Alkalemia during continuous renal replacement therapy
    Journois, Didier
    CRITICAL CARE MEDICINE, 2008, 36 (11) : 3119 - 3120
  • [37] Pharmacokinetics during continuous renal replacement therapy
    Keller, E
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (02): : 113 - 117
  • [38] Iloprost for additional anticoagulation in continuous renal replacement therapy - A pilot study
    Birnbaum, Jurgen
    Spies, Claudia D.
    Klotz, Edda
    Hein, Ortrud Vargas
    Morgera, Stanislao
    Schink, Tania
    Ziemer, Sabine
    Grund, Mona S.
    Saalmann, Rene
    Kox, Wolfgang J.
    Lehmann, Christian
    RENAL FAILURE, 2007, 29 (03) : 271 - 277
  • [39] Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration
    Thabit, Abrar K.
    Hamada, Yukihiro
    Nicolau, David P.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (01) : E47 - E54
  • [40] To increase or decrease dosage of antimicrobials in septic patients during continuous renal replacement therapy: the eternal doubt
    Wong, Wai-Tat
    Choi, Gordon
    Gomersall, Charles D.
    Lipman, Jeffrey
    CURRENT OPINION IN PHARMACOLOGY, 2015, 24 : 68 - 76
12345